Todays Report: Today, Ra Pharmaceuticals Inc (RARX) Coverage Initiated at Jefferies Group

Today, Ra Pharmaceuticals Inc (RARX) Coverage Initiated at Jefferies Group

Jefferies Group assumed coverage on shares of Ra Pharmaceuticals Inc (NASDAQ:RARX) in a report published on Monday morning. The brokerage issued a buy rating and a $25.00 target price on the stock.

Separately, SunTrust Banks Inc. assumed coverage on Ra Pharmaceuticals in a research report on Monday. They set a buy rating and a $32.00 target price on the stock.

Ra Pharmaceuticals (NASDAQ:RARX) opened at 13.00 on Monday. The firm’s market cap is $7.20 million. Ra Pharmaceuticals has a 52-week low of $12.33 and a 52-week high of $14.86. The firm’s 50 day moving average price is $13.17 and its 200 day moving average price is $13.17.

In other Ra Pharmaceuticals news, Director Rajeev M. Shah bought 161,538 shares of the business’s stock in a transaction that occurred on Monday, October 31st. The shares were bought at an average price of $13.00 per share, for a total transaction of $2,099,994.00. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, major shareholder Harry R. Weller bought 338,462 shares of the business’s stock in a transaction that occurred on Monday, October 31st. The shares were acquired at an average price of $13.00 per share, for a total transaction of $4,400,006.00. The disclosure for this purchase can be found here.

About Ra Pharmaceuticals

Related posts

Leave a Comment